Analysts expect Perspective Therapeutics, Inc. to report revenue of 76,968.20 for Q3 26, against a range of 74,175.87 to 79,760.53. The most recent reported quarter, Q2 26, came in at 81,000.00, a 15.7% miss against the 96,048.71 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 369,000.00 | 234,000.00 | 342,000.00 | 290,000.00 | 209,000.00 | 43,000.00 | 76,000.00 | 81,000.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 321,663.61 | 283,046.63 | 150,322.34 | 231,606.02 | 251,818.42 | 233,231.37 | 161,175.94 | 103,957.94 | 79,760.53 | 81,714.92 | 140,263.56 | 93,329.61 | 70,387.63 | 68,153.91 | 353,696.12 | 241,359.89 | ||||||||||
| Low Estimate | 278,529.53 | 247,492.05 | 123,496.32 | 203,446.38 | 210,341.84 | 212,165.43 | 139,094.08 | 88,139.48 | 74,175.87 | 71,866.52 | 123,105.84 | 77,515.19 | 63,949.27 | 56,379.63 | 322,929.94 | 226,267.23 | ||||||||||
| Consensus Estimate | 300,096.57 | 265,269.34 | 136,909.33 | 217,526.20 | 231,080.13 | 222,698.40 | 150,135.01 | 96,048.71 | 76,968.20 | 76,790.72 | 131,684.70 | 85,422.40 | 67,168.45 | 62,266.77 | 338,313.03 | 233,813.56 |
Analysts expect Perspective Therapeutics, Inc. to report earnings per share of -0.23 for Q3 26, against a range of -0.25 to -0.21. The most recent reported quarter, Q2 26, came in at -0.22, a 18.5% beat against the -0.27 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.21 | -0.57 | -0.25 | -0.30 | -0.35 | -0.51 | -0.25 | -0.22 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.20 | -0.25 | -0.26 | -0.27 | -0.31 | -0.32 | -0.26 | -0.26 | -0.21 | -0.26 | -0.23 | -0.22 | -0.26 | -0.26 | -0.16 | -0.20 | ||||||||||
| Low Estimate | -0.22 | -0.31 | -0.30 | -0.29 | -0.35 | -0.38 | -0.30 | -0.28 | -0.25 | -0.28 | -0.25 | -0.26 | -0.30 | -0.30 | -0.18 | -0.22 | ||||||||||
| Consensus Estimate | -0.21 | -0.28 | -0.28 | -0.28 | -0.33 | -0.35 | -0.28 | -0.27 | -0.23 | -0.27 | -0.24 | -0.24 | -0.28 | -0.28 | -0.17 | -0.21 |